Filing Flows › NextPlat (NXPL) › Q2 2026 › vs Q1 2026
NextPlat (NXPL) Q2 2026 vs Q1 2026 (quarter over quarter)
NextPlat's revenue rose $2.0M (+21%) from $9.9M in Q1 2026 to $11.9M in Q2 2026. The biggest changes: E-Commerce Revenue +$879K (+27%); Pharmacy Prescription and Other Revenue, Net of PBM Fees +$780K (+16%); Pharmacy Contract Revenue +$367K (+20%).
NextPlat, Q2 2026: revenue $11.9M (-10% year over year), operating margin -1.1%, net loss $144K, operating cash flow $1.1M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Pharmacy Prescription and Other Revenue, Net of PBM Fees | $5.6M | $4.8M | $780K | +16% |
| E-Commerce Revenue | $4.1M | $3.2M | $879K | +27% |
| Pharmacy Contract Revenue | $2.2M | $1.9M | $367K | +20% |
| Revenue | $11.9M | $9.9M | $2.0M | +21% |
| Net loss | $144K | $1.1M | −$988K | -87% |
| Costs & expenses | $12.1M | $11.0M | $1.1M | +10% |
| Operating costs | $12.0M | $11.0M | $1.1M | +10% |
| Income tax | $48K | $0 | $48K | — |
| Cost of revenue | $7.2M | $6.4M | $744K | +12% |
| SG&A | $2.4M | $2.0M | $439K | +22% |
| Other operating costs | $2.4M | $2.5M | −$133K | -5% |
| Operating cash sources | $1.2M | −$1.8M | $3.0M | — |
| Depreciation & amortization | $80K | $90K | −$10K | -11% |
| Working capital & other | $1.1M | −$1.8M | $3.0M | — |
| Net loss absorbed | $144K | $1.1M | −$988K | -87% |
| Operating cash flow | $1.1M | −$2.6M | $3.7M | — |
Questions
How much did NextPlat's revenue grow quarter over quarter in Q2 2026?
NextPlat's revenue rose $2.0M (+21%) from $9.9M in Q1 2026 to $11.9M in Q2 2026.
What drove NextPlat's revenue change in Q2 2026?
E-Commerce Revenue +$879K (+27%); Pharmacy Prescription and Other Revenue, Net of PBM Fees +$780K (+16%); Pharmacy Contract Revenue +$367K (+20%).